This shows that quercetin enhances the effects of BET inhibitor JQ1 by inhibiting expression of the hnRNPA1 gene, and combined administration may have promising application prospects for cancer patients, especially regarding patients with thyroid and pancreatic cancer. This evidence concerns the gene HNRNPA1 and cancer.